HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Phthalates, Lead, Fragrance Materials Among “Unfounded” Scares Of 2012

This article was originally published in The Rose Sheet

Executive Summary

The American Council on Science and Health again includes media frenzies around ingredients in cosmetic products on its annual list of the Top Ten Unfounded Health Scares.

You may also be interested in...



PCPC Sees Opportunity For Industry Narrative Amid Public Cries For Transparency

Calls for greater transparency in personal-care ingredient use and other business practices should be seen as an opportunity, Personal Care Products Council leadership suggests.

Women’s Voices Join In Fragrance Disclosure Debate, Citing Allergy Risks

NGO Women’s Voices for the Earth says the rising incidence of fragrance allergy worldwide points to a need for fragrance ingredient disclosure. In an online petition, the group is calling on IFRA to establish “an industry-wide policy” of full transparency so consumers can make informed choices about fragranced product use.

IFRA Works To Block Legislation Limiting Fragrance Ingredients

The trade group seeks to prevent the European Commission from passing legislation recommended by the Scientific Committee on Consumer Safety to strongly limit the use of certain fragrance ingredients. IFRA’s work plan seeks to address fragrance contact allergy without establishing such limits.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018437

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel